Skip to main content
Top
Published in: European Journal of Clinical Microbiology & Infectious Diseases 9/2016

01-09-2016 | Original Article

Preliminary study on serum paraoxonase-1 status and chemokine (C-C motif) ligand 2 in hospitalized elderly patients with catheter-associated asymptomatic bacteriuria

Authors: S. Iftimie, A. García-Heredia, I. Pujol, F. Ballester, I. Fort-Gallifa, J. M. Simó, J. Joven, J. Camps, A. Castro

Published in: European Journal of Clinical Microbiology & Infectious Diseases | Issue 9/2016

Login to get access

Abstract

Urinary tract infections (UTI) are common among elderly patients in residential care facilities, as well as in the hospital setting. Identifying new biochemical markers of UTI is an active line of research since UTI management is resource intensive. Paraoxonase-1 (PON1) forms part of the patient’s immune system, the response-to-injury and inflammation. Our study sought to evaluate alterations in inflammation-related paraoxonase-1 (PON1) and chemokine (C-C motif) ligand 2 (CCL2) in patients with an indwelling catheter to assess their potential usefulness as biomarkers of infection. Patients (n = 142) who had had the urinary catheter removed and 100 healthy volunteers were recruited. In all participants we measured serum PON1 activity, PON1 concentration, CCL2, procalcitonin and C-reactive protein (CRP). Results indicated that patients had higher CCL2, CRP and procalcitonin concentrations than the control group, and lower paraoxonase activity. There were no significant differences in PON1 concentrations. When comparing the diagnostic accuracy of CRP, procalcitonin, CCL2 and the PON1-related variables in discriminating between patients with and those without UTI, we found a considerable degree of overlap between groups, i.e., a low diagnostic accuracy. However, there were significant inverse logarithmic correlations between serum paraoxonase activity and the number of days the urinary catheter had been in situ. Our results suggest that measurement of these biochemical variables may be useful in investigating complications of long-term use of these devices and help to improve the economic and clinical investment required in the management of the often-associated infection.
Literature
1.
go back to reference High KP, Bradley SF, Gravenstein S, Mehr DR, Quagliarello VJ, Richards C, Yoshikawa TT (2009) Clinical practice guideline for the evaluation of fever and infection in older adult residents of long-term care facilities: 2008 update by the infectious diseases society of America. Clin Infect Dis 48(2):149–171CrossRefPubMed High KP, Bradley SF, Gravenstein S, Mehr DR, Quagliarello VJ, Richards C, Yoshikawa TT (2009) Clinical practice guideline for the evaluation of fever and infection in older adult residents of long-term care facilities: 2008 update by the infectious diseases society of America. Clin Infect Dis 48(2):149–171CrossRefPubMed
2.
go back to reference Nicolle LE (2014) Catheter-related urinary tract infection: practical management in the elderly. Drugs Aging 31(1):1–10CrossRefPubMed Nicolle LE (2014) Catheter-related urinary tract infection: practical management in the elderly. Drugs Aging 31(1):1–10CrossRefPubMed
4.
go back to reference Theodorou VP, Papaioannou VE, Tripsianis GA, Panopoulou MK, Christophoridis EK, Kouliatsis GA, Gioka TM, Maltezos ES, Ktenidou-Kartali SI, Pneumatikos IA (2012) Procalcitonin and procalcitonin kinetics for diagnosis and prognosis of intravascular catheter-related bloodstream infections in selected critically ill patients: a prospective observational study. BMC Infect Dis 12:247CrossRefPubMedPubMedCentral Theodorou VP, Papaioannou VE, Tripsianis GA, Panopoulou MK, Christophoridis EK, Kouliatsis GA, Gioka TM, Maltezos ES, Ktenidou-Kartali SI, Pneumatikos IA (2012) Procalcitonin and procalcitonin kinetics for diagnosis and prognosis of intravascular catheter-related bloodstream infections in selected critically ill patients: a prospective observational study. BMC Infect Dis 12:247CrossRefPubMedPubMedCentral
5.
go back to reference Nicolle LE, Bradley S, Colgan R, Rice JC, Schaeffer A, Hooton TM, Infectious Diseases Society of America; American Society of Nephrology; American Geriatric Society (2005) Infectious Diseases Society of America Guidelines for the diagnosis and treatment of symptomatic bacteriuria in adults. Clin Infect Dis 40(5):643–654CrossRefPubMed Nicolle LE, Bradley S, Colgan R, Rice JC, Schaeffer A, Hooton TM, Infectious Diseases Society of America; American Society of Nephrology; American Geriatric Society (2005) Infectious Diseases Society of America Guidelines for the diagnosis and treatment of symptomatic bacteriuria in adults. Clin Infect Dis 40(5):643–654CrossRefPubMed
6.
go back to reference Zhanel GG, Harding GK, Guay DR (1990) Asymptomatic bacteriuria. Which patients should be treated. Arch Intern Med 150(7):1389–1396CrossRefPubMed Zhanel GG, Harding GK, Guay DR (1990) Asymptomatic bacteriuria. Which patients should be treated. Arch Intern Med 150(7):1389–1396CrossRefPubMed
7.
go back to reference Nicolle LE (2000) Asymptomatic bacteriuria in institutionalized elderly people; evidence and practice. CMAJ 163(3):285–286PubMedPubMedCentral Nicolle LE (2000) Asymptomatic bacteriuria in institutionalized elderly people; evidence and practice. CMAJ 163(3):285–286PubMedPubMedCentral
9.
go back to reference Iftimie S, García-Heredia A, Pujol I, Ballester F, Fort-Gallifa I, Simó JM, Joven J, Castro A, Camps J (2015) A preliminary study of paraoxonase-1 in infected patients with an indwelling central venous catheter. Clin Biochem 49(6):449–457. doi:10.1016/j.clinbiochem.2015.11.006 Iftimie S, García-Heredia A, Pujol I, Ballester F, Fort-Gallifa I, Simó JM, Joven J, Castro A, Camps J (2015) A preliminary study of paraoxonase-1 in infected patients with an indwelling central venous catheter. Clin Biochem 49(6):449–457. doi:10.​1016/​j.​clinbiochem.​2015.​11.​006
10.
go back to reference Camps J, Marsillach J, Joven J (2009) The paraoxonases: role in human diseases and methodological difficulties in measurement. Crit Rev Clin Lab Sci 46(2):83–106CrossRefPubMed Camps J, Marsillach J, Joven J (2009) The paraoxonases: role in human diseases and methodological difficulties in measurement. Crit Rev Clin Lab Sci 46(2):83–106CrossRefPubMed
11.
go back to reference Mete R, Oran M, Alpsoy S, Gunes H, Tulubas F, Turan C, Topcu B, Aydin M, Yildirim O (2013) Carotid intima-media thickness and serum paraoxonase-1 activity in patients with Helicobacter pylori. Eur Rev Med Pharmacol Sci 17(21):2884–2889PubMed Mete R, Oran M, Alpsoy S, Gunes H, Tulubas F, Turan C, Topcu B, Aydin M, Yildirim O (2013) Carotid intima-media thickness and serum paraoxonase-1 activity in patients with Helicobacter pylori. Eur Rev Med Pharmacol Sci 17(21):2884–2889PubMed
12.
go back to reference Parra S, Marsillach J, Aragonés G, Beltrán R, Montero M, Coll B, Mackness B, Mackness M, Alonso-Villaverde C, Joven J, Camps J (2010) Paraoxonase-1 gene haplotypes are associated with metabolic disturbances, atherosclerosis, and immunologic outcome in HIV-infected patients. J Infect Dis 201(4):627–634CrossRefPubMed Parra S, Marsillach J, Aragonés G, Beltrán R, Montero M, Coll B, Mackness B, Mackness M, Alonso-Villaverde C, Joven J, Camps J (2010) Paraoxonase-1 gene haplotypes are associated with metabolic disturbances, atherosclerosis, and immunologic outcome in HIV-infected patients. J Infect Dis 201(4):627–634CrossRefPubMed
14.
go back to reference McCabe WR, Jackson GG (1962) Gram-negative bacteremia. I. Etiology and ecology. Arch Intern Med 110:847–864CrossRef McCabe WR, Jackson GG (1962) Gram-negative bacteremia. I. Etiology and ecology. Arch Intern Med 110:847–864CrossRef
15.
go back to reference Berkman LF, Leo-Summers L, Horwitz RI (1992) Emotional support and survival after myocardial infarction. A prospective, population-based study of the elderly. Ann Intern Med 117(12):1003–1009CrossRefPubMed Berkman LF, Leo-Summers L, Horwitz RI (1992) Emotional support and survival after myocardial infarction. A prospective, population-based study of the elderly. Ann Intern Med 117(12):1003–1009CrossRefPubMed
16.
go back to reference Ferré N, Camps J, Fernández-Ballart J, Arija V, Murphy MM, Ceruelo S, Biarnés E, Vilella E, Tous M, Joven J (2003) Regulation of serum paraoxonase activity by genetic, nutritional, and lifestyle factors in the general population. Clin Chem 49(9):1491–1497CrossRefPubMed Ferré N, Camps J, Fernández-Ballart J, Arija V, Murphy MM, Ceruelo S, Biarnés E, Vilella E, Tous M, Joven J (2003) Regulation of serum paraoxonase activity by genetic, nutritional, and lifestyle factors in the general population. Clin Chem 49(9):1491–1497CrossRefPubMed
17.
go back to reference Marsillach J, Aragonès G, Beltrán R, Caballeria J, Pedro-Botet J, Morcillo-Suárez C, Navarro A, Joven J, Camps J (2009) The measurement of the lactonase activity of paraoxonase-1 in the clinical evaluation of patients with chronic liver impairment. Clin Biochem 42(1–2):91–98CrossRefPubMed Marsillach J, Aragonès G, Beltrán R, Caballeria J, Pedro-Botet J, Morcillo-Suárez C, Navarro A, Joven J, Camps J (2009) The measurement of the lactonase activity of paraoxonase-1 in the clinical evaluation of patients with chronic liver impairment. Clin Biochem 42(1–2):91–98CrossRefPubMed
18.
go back to reference Martinelli N, Garcia-Heredia A, Roca H, Aranda N, Arija V, Mackness B, Busti F, Aragonès G, Pedro-Botet J, Pedica F, Cataldo I, Marsillach J, Joven J, Girelli D, Camps J (2013) Paraoxonase-1 status in patients with hereditary hemochromatosis. J Lipid Res 54(5):1484–1492CrossRefPubMedPubMedCentral Martinelli N, Garcia-Heredia A, Roca H, Aranda N, Arija V, Mackness B, Busti F, Aragonès G, Pedro-Botet J, Pedica F, Cataldo I, Marsillach J, Joven J, Girelli D, Camps J (2013) Paraoxonase-1 status in patients with hereditary hemochromatosis. J Lipid Res 54(5):1484–1492CrossRefPubMedPubMedCentral
19.
go back to reference Andreu A, Cacho J, Coira A, Lepe JA (2011) Diagnóstico microbiológico de las infecciones del tracto urinario. Enferm Infecc Microbiol Clin 29:52–57CrossRefPubMed Andreu A, Cacho J, Coira A, Lepe JA (2011) Diagnóstico microbiológico de las infecciones del tracto urinario. Enferm Infecc Microbiol Clin 29:52–57CrossRefPubMed
20.
go back to reference Zweig MH, Campbell G (1993) Receiver-operating characteristic (ROC) plots: a fundamental evaluation tool in clinical medicine. Clin Chem 39(4):561–577PubMed Zweig MH, Campbell G (1993) Receiver-operating characteristic (ROC) plots: a fundamental evaluation tool in clinical medicine. Clin Chem 39(4):561–577PubMed
21.
go back to reference Aviram M, Rosenblat M, Billecke S, Erogul J, Sorenson R, Bisgaier CL, Newton RS, La Du B (1999) Human serum paraoxonase (PON1) is inactivated by oxidized low density lipoprotein and preserved by antioxidants. Free Rad Biol Med 26(7–8):892–904CrossRefPubMed Aviram M, Rosenblat M, Billecke S, Erogul J, Sorenson R, Bisgaier CL, Newton RS, La Du B (1999) Human serum paraoxonase (PON1) is inactivated by oxidized low density lipoprotein and preserved by antioxidants. Free Rad Biol Med 26(7–8):892–904CrossRefPubMed
22.
go back to reference Camps J, Mackness M, Mackness B, Marsillach J, Joven J (2010) Serum paraoxonase-1 activity and genetic polymorphisms: common errors in measurement and interpretation of results. Clin Chem Lab Med 48(6):893–894CrossRefPubMed Camps J, Mackness M, Mackness B, Marsillach J, Joven J (2010) Serum paraoxonase-1 activity and genetic polymorphisms: common errors in measurement and interpretation of results. Clin Chem Lab Med 48(6):893–894CrossRefPubMed
23.
go back to reference Camps J, Rodríguez-Gallego E, García-Heredia A, Triguero I, Riera-Borrull M, Hernández-Aguilera A, Luciano-Mateo F, Fernández-Arroyo S, Joven J (2014) Paraoxonases and chemokine (C-C motif) ligand-2 in noncommunicable diseases. Adv Clin Chem 63:247–308CrossRefPubMed Camps J, Rodríguez-Gallego E, García-Heredia A, Triguero I, Riera-Borrull M, Hernández-Aguilera A, Luciano-Mateo F, Fernández-Arroyo S, Joven J (2014) Paraoxonases and chemokine (C-C motif) ligand-2 in noncommunicable diseases. Adv Clin Chem 63:247–308CrossRefPubMed
24.
go back to reference Charo IF, Taubman MB (2004) Chemokines in the pathogenesis of vascular disease. Circ Res 95(9):858–866CrossRefPubMed Charo IF, Taubman MB (2004) Chemokines in the pathogenesis of vascular disease. Circ Res 95(9):858–866CrossRefPubMed
25.
go back to reference Mackness B, Hine D, Liu Y, Mastorikou M, Mackness M (2004) Paraoxonase-1 inhibits oxidised LDL-induced MCP-1 production by endothelial cells. Biochem Biophys Res Commun 318(3):680–683CrossRefPubMed Mackness B, Hine D, Liu Y, Mastorikou M, Mackness M (2004) Paraoxonase-1 inhibits oxidised LDL-induced MCP-1 production by endothelial cells. Biochem Biophys Res Commun 318(3):680–683CrossRefPubMed
26.
go back to reference Rodríguez-Sanabria F, Rull A, Beltrán-Debón R, Aragonès G, Camps J, Mackness B, Mackness M, Joven J (2010) Tissue distribution and expression of paraoxonases and chemokines in mouse: the ubiquitous and joint localisations suggest a systemic and coordinated role. J Mol Histol 41(6):379–386CrossRefPubMed Rodríguez-Sanabria F, Rull A, Beltrán-Debón R, Aragonès G, Camps J, Mackness B, Mackness M, Joven J (2010) Tissue distribution and expression of paraoxonases and chemokines in mouse: the ubiquitous and joint localisations suggest a systemic and coordinated role. J Mol Histol 41(6):379–386CrossRefPubMed
27.
go back to reference Rull A, Camps J, Alonso-Villaverde C, Joven J (2010) Insulin resistance, inflammation, and obesity: role of monocyte chemoattractant protein-1 (or CCL2) in the regulation of metabolism. Mediators Inflamm Rull A, Camps J, Alonso-Villaverde C, Joven J (2010) Insulin resistance, inflammation, and obesity: role of monocyte chemoattractant protein-1 (or CCL2) in the regulation of metabolism. Mediators Inflamm
28.
go back to reference Petrkova J, Szotkowska J, Hermanova Z, Lukl J, Petrek M (2004) Monocyte chemoattractant protein-1 in patients with peripheral arterial disease. Mediat Inflamm 13(1):39–43CrossRef Petrkova J, Szotkowska J, Hermanova Z, Lukl J, Petrek M (2004) Monocyte chemoattractant protein-1 in patients with peripheral arterial disease. Mediat Inflamm 13(1):39–43CrossRef
29.
go back to reference Sans T, Rull A, Luna J, Mackness B, Mackness M, Joven J, Ibañez M, Pariente R, Rodriguez M, Ortin X, Masdeu G, Camps J (2012) Monocyte chemoattractant protein-1 and paraoxonase-1 and 3 levels in patients with sepsis treated in an intensive care unit: a preliminary report. Clin Chem Lab Med 50(8):1409–1415CrossRefPubMed Sans T, Rull A, Luna J, Mackness B, Mackness M, Joven J, Ibañez M, Pariente R, Rodriguez M, Ortin X, Masdeu G, Camps J (2012) Monocyte chemoattractant protein-1 and paraoxonase-1 and 3 levels in patients with sepsis treated in an intensive care unit: a preliminary report. Clin Chem Lab Med 50(8):1409–1415CrossRefPubMed
30.
go back to reference Ramanathan R, Duane TM (2014) Urinary tract infections in surgical patients. Surg Clin Borth Am 94(6):1351–1368CrossRef Ramanathan R, Duane TM (2014) Urinary tract infections in surgical patients. Surg Clin Borth Am 94(6):1351–1368CrossRef
31.
go back to reference Becknell B, Schober M, Korbel L, Spencer JD (2015) The diagnosis, evaluation and treatment of acute and recurrent pediatric urinary tract infections. Expert Rev Anti Infect Ther 13(1):81–90CrossRefPubMed Becknell B, Schober M, Korbel L, Spencer JD (2015) The diagnosis, evaluation and treatment of acute and recurrent pediatric urinary tract infections. Expert Rev Anti Infect Ther 13(1):81–90CrossRefPubMed
32.
go back to reference Khasriya R, Khan S, Lunawat R, Bishara S, Bignall J, Malone-Lee M, Ishii H, O’Connor D, Kelsey M, Malone-Lee J (2010) The inadequacy of urinary dipstick and microscopy as surrogate markers of urinary tract infection in urological outpatients with lower urinary tract symptoms without acute frequency and dysuria. J Urol 183(5):1843–1847CrossRefPubMed Khasriya R, Khan S, Lunawat R, Bishara S, Bignall J, Malone-Lee M, Ishii H, O’Connor D, Kelsey M, Malone-Lee J (2010) The inadequacy of urinary dipstick and microscopy as surrogate markers of urinary tract infection in urological outpatients with lower urinary tract symptoms without acute frequency and dysuria. J Urol 183(5):1843–1847CrossRefPubMed
33.
go back to reference Wang H, Yin F, Shen DX, Zhang YJ, Luo YP, Liu CJ, Wang KF, Zhou G, Ye LY, Chen G, Wang XN (2013) Predictive value of procalcitonin for excluding bloodstream infection: results of a retrospective study and utility of a rapid, quantitative test for procalcitonin. J Int Med Res 41(5):1671–1681CrossRefPubMed Wang H, Yin F, Shen DX, Zhang YJ, Luo YP, Liu CJ, Wang KF, Zhou G, Ye LY, Chen G, Wang XN (2013) Predictive value of procalcitonin for excluding bloodstream infection: results of a retrospective study and utility of a rapid, quantitative test for procalcitonin. J Int Med Res 41(5):1671–1681CrossRefPubMed
34.
go back to reference Feneley RC, Kunin CM, Stickler DJ (2012) An indwelling urinary catheter for the 21st century. BJU Int 109(12):1746–1749CrossRefPubMed Feneley RC, Kunin CM, Stickler DJ (2012) An indwelling urinary catheter for the 21st century. BJU Int 109(12):1746–1749CrossRefPubMed
35.
go back to reference Camps J, Pujol I, Ballester F, Joven J, Simó JM (2011) Paraoxonases as potential antibiofilm agents: their relationship with quorum-sensing signals in Gram-negative bacteria. Antimicrob Agents Chemother 55(4):1325–1331CrossRefPubMedPubMedCentral Camps J, Pujol I, Ballester F, Joven J, Simó JM (2011) Paraoxonases as potential antibiofilm agents: their relationship with quorum-sensing signals in Gram-negative bacteria. Antimicrob Agents Chemother 55(4):1325–1331CrossRefPubMedPubMedCentral
36.
go back to reference Liu YC, Chan KG, Chang CY (2015) Modulation of host biology by Pseudomonas aeruginosa quorum sensing signal molecules: Messengers or traitors. Front Microbiol 6:1226PubMedPubMedCentral Liu YC, Chan KG, Chang CY (2015) Modulation of host biology by Pseudomonas aeruginosa quorum sensing signal molecules: Messengers or traitors. Front Microbiol 6:1226PubMedPubMedCentral
37.
go back to reference Ozer EA, Pezzulo A, Shih DM, Chun C, Furlong C, Lusis AJ, Greenberg EP, Zabner J (2005) Human and murine paraoxonase 1 are host modulators of Pseudomonas aeruginosa quorum sensing. FEMS Microbiol Lett 253(1):29–37CrossRefPubMed Ozer EA, Pezzulo A, Shih DM, Chun C, Furlong C, Lusis AJ, Greenberg EP, Zabner J (2005) Human and murine paraoxonase 1 are host modulators of Pseudomonas aeruginosa quorum sensing. FEMS Microbiol Lett 253(1):29–37CrossRefPubMed
38.
go back to reference Schweikert EM, Amort J, Wilgenbus P, Förstermann U, Teiber JF, Horke S (2012) Paraoxonases-2 and −3 are important defense enzymes against Pseudomonas aeruginosa virulence factors due to their anti-oxidative and anti-inflammatory properties. J Lipids 2012:352857CrossRefPubMedPubMedCentral Schweikert EM, Amort J, Wilgenbus P, Förstermann U, Teiber JF, Horke S (2012) Paraoxonases-2 and −3 are important defense enzymes against Pseudomonas aeruginosa virulence factors due to their anti-oxidative and anti-inflammatory properties. J Lipids 2012:352857CrossRefPubMedPubMedCentral
Metadata
Title
Preliminary study on serum paraoxonase-1 status and chemokine (C-C motif) ligand 2 in hospitalized elderly patients with catheter-associated asymptomatic bacteriuria
Authors
S. Iftimie
A. García-Heredia
I. Pujol
F. Ballester
I. Fort-Gallifa
J. M. Simó
J. Joven
J. Camps
A. Castro
Publication date
01-09-2016
Publisher
Springer Berlin Heidelberg
Published in
European Journal of Clinical Microbiology & Infectious Diseases / Issue 9/2016
Print ISSN: 0934-9723
Electronic ISSN: 1435-4373
DOI
https://doi.org/10.1007/s10096-016-2679-8

Other articles of this Issue 9/2016

European Journal of Clinical Microbiology & Infectious Diseases 9/2016 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.